Last updated: June 14, 2026
Back to directoryAI-developed urine culture imaging application for BD Kiestra workflows that supports standardized plate imaging and laboratory staff interpretation.
Microbiology labs already using or considering BD Kiestra automation and wanting AI-supported urine culture plate review with standardized images and worklists.
Compare within workflow: Laboratory and hematology diagnostics · comparison shortlist · source index
| Status | BD product materials describe an AI-developed urine culture application; verify country-specific clearance and distinguish it from BD's FDA-cleared MRSA AI application. |
|---|---|
| Review route | Local IVD authorization, FDA/CE verification, and BD product labeling review |
| Intended use | AI-supported standardized urine culture plate imaging and workflow organization for qualified laboratory interpretation. |
| Verification note | Confirm application, media, specimen type, BD Synapsys workflow, ReadA/TLA configuration, and cleared regional intended use. |
| Source | www.bd.com / en-sea / products-and-solutions |
Product-specific review. These product-specific signals summarize what the cited sources imply before treating BD Kiestra Urine Culture Application as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Verify local authorization for the exact urine culture application, BD Kiestra hardware, ReadA, BD Synapsys workflow, media, specimen type, and intended use before clinical result workflow changes. |
|---|---|
| Privacy | Review BD Synapsys and LIS data flows, plate-image retention, patient identifiers, access controls, audit logs, service access, cybersecurity, backups, and data-processing agreements. |
| Evidence | Validate against local urine culture protocols, media, incubation times, organism prevalence, negative-rate assumptions, significant-growth rules, technologist review, and discrepancy handling. |
| Workflow | Best governed as AI-assisted microbiology imaging support where qualified staff interpret results, review exceptions, maintain culture protocols, reconcile LIS reporting, and monitor post-deployment performance. |
BD describes the Kiestra Urine Culture Application as an AI-developed application that enables standardized plate imaging and workflow efficiency through BD Synapsys informatics. BD announcements separately describe FDA clearance for the Kiestra MRSA AI imaging application and device listing for ReadA, so labs should verify the exact urine application authorization in their market.
Not for: Autonomous urine culture diagnosis, unsupported media or specimen types, replacing qualified microbiology review, or assuming all regional product pages match local clearance.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
FDA-cleared automated culture plate reader from Clever Culture Systems, distributed by Thermo Fisher in the U.S. and Europe, using AI algorithms for microbiology plate triage.
AI-enabled full-field digital cell morphology platform for hematology labs reviewing blood smears and bone marrow aspirates with professional oversight.
Automated digital cell morphology system that captures and pre-classifies blood cells so trained laboratory staff can review and verify differentials.
Digital hematology morphology analyzer for lower-volume labs that captures blood smear images and helps staff review pre-classified cells.